Bath & Body Works (NYSE:BBWI) Issues Earnings Results

Key Points

• Bath & Body Works reported $0.37 earnings per share for the quarter, exceeding analysts' expectations of $0.36.
• The company updated its Q3 2025 EPS guidance range to $0.370-0.45 and its FY 2025 guidance to $3.350-3.600.
• A dividend of $0.20 per share will be paid on September 5th, representing a 2.5% yield with a payout ratio of 21.33%.

Bath & Body Works (NYSE:BBWI - Get Free Report) announced its earnings results on Thursday. The company reported $0.37 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.37, Zacks reports. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The company had revenue of $1.55 billion for the quarter, compared to analysts' expectations of $1.55 billion. During the same quarter in the previous year, the company posted $0.37 EPS. The firm's quarterly revenue was down .8% on a year-over-year basis. Bath & Body Works updated its Q3 2025 guidance to 0.370-0.45 EPS and its FY 2025 guidance to 3.350-3.600 EPS.

Bath & Body Works Stock Up 0.2%

NYSE:BBWI traded up $0.06 on Tuesday, reaching $29.27. 2,490,806 shares of the company's stock were exchanged, compared to its average volume of 5,186,003. The firm has a market capitalization of $6.03 billion, a price-to-earnings ratio of 8.68, a price-to-earnings-growth ratio of 0.98 and a beta of 1.49. The business has a fifty day moving average of $30.64 and a 200-day moving average of $30.69. Bath & Body Works has a 52-week low of $24.94 and a 52-week high of $41.87.

Bath & Body Works Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 5th. Shareholders of record on Friday, August 22nd will be paid a dividend of $0.20 per share. The ex-dividend date is Friday, August 22nd. This represents a $0.80 dividend on an annualized basis and a yield of 2.7%. Bath & Body Works's dividend payout ratio is 23.74%.

Hedge Funds Weigh In On Bath & Body Works

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Alliancebernstein L.P. boosted its holdings in Bath & Body Works by 5.8% in the second quarter. Alliancebernstein L.P. now owns 5,737,796 shares of the company's stock valued at $171,904,000 after purchasing an additional 315,738 shares in the last quarter. AQR Capital Management LLC boosted its holdings in Bath & Body Works by 5.3% in the second quarter. AQR Capital Management LLC now owns 4,203,326 shares of the company's stock valued at $125,322,000 after purchasing an additional 210,153 shares in the last quarter. Makaira Partners LLC boosted its holdings in Bath & Body Works by 12.2% in the second quarter. Makaira Partners LLC now owns 1,839,039 shares of the company's stock valued at $55,098,000 after purchasing an additional 200,000 shares in the last quarter. Balyasny Asset Management L.P. boosted its holdings in Bath & Body Works by 63.0% in the second quarter. Balyasny Asset Management L.P. now owns 1,120,926 shares of the company's stock valued at $33,583,000 after purchasing an additional 433,309 shares in the last quarter. Finally, Raymond James Financial Inc. boosted its holdings in Bath & Body Works by 2.4% in the second quarter. Raymond James Financial Inc. now owns 692,988 shares of the company's stock valued at $20,762,000 after purchasing an additional 16,339 shares in the last quarter. 95.14% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have recently commented on BBWI shares. Piper Sandler set a $39.00 price target on Bath & Body Works and gave the stock an "overweight" rating in a report on Thursday, May 15th. The Goldman Sachs Group reduced their price target on Bath & Body Works from $44.00 to $43.00 and set a "buy" rating on the stock in a report on Friday, May 30th. Telsey Advisory Group reiterated an "outperform" rating and set a $38.00 price target on shares of Bath & Body Works in a report on Thursday, August 28th. UBS Group reduced their price target on Bath & Body Works from $36.00 to $32.00 and set a "neutral" rating on the stock in a report on Friday. Finally, Morgan Stanley reduced their price target on Bath & Body Works from $49.00 to $43.00 and set an "overweight" rating on the stock in a report on Tuesday, May 6th. Twelve investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $41.62.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.